Taking in account the high prevalence of diabetic nephropathy in the Indian population, it would be very interesting to know if there has been any evidence of variation in responses to ACE inhibition on the basis of angiotensin-converting enzyme gene polymorphism in type II diabetics with nephropathy in the Indian population. The gene discussed is ACE; the disease is Nephropathy.